In partnership with the Fraunhofer Center for Molecular Biotechnology and the Walter Reid Army Institute for Research, the Sabin Vaccine Institute has successfully expressed the hookworm-derived antigen Na-APR-1.

Dr. Peter Hotez, Sabin’s President, recently authored an op-ed in The Hinducalling on a new modern India to “invest in neglected tropical disease (NTD) elimination efforts--including the development of drugs, diagnostics, and vaccines--that will reduce the large NTD burden in South Asia.”

Statement from Sabin Vaccine Institute on the Passing of Honorable Richard C. Holbrooke

The Sabin Vaccine Institute expresses its deepest condolences to family, friends and colleagues of the Honorable Richard C. Holbrooke, who died yesterday.

Ambassador Holbrooke, a diplomat, AIDS activist, and public servant, was the recipient of Sabin’s 2002 Lifetime Achievement Award for leadership and dedication to securing adequate healthcare for the world’s most vulnerable populations. He clearly recognized the strong relationship between science, medicine and diplomacy for the benefit of humanity.

Sabin

Pages

Subscribe to RSS - Sabin Vaccine Development